This study presents the first comprehensive comparison of glycomic profiles in early AIS from mouse brain tissue and human serum, identifying a conserved fucosylation deficiency as a potential class of diagnostic indicators for clinical detection and therapeutic targeting. The observed deficiency was correlated with a potential mechanistic link to dysregulated glycan-mediated inflammatory responses and impaired cellular stress response pathways.
Wu et al. (Wed,) studied this question.